Literature DB >> 25410812

Long-term outcome after deferral of revascularization in patients with intermediate coronary stenosis and gray-zone fractional flow reserve.

Yasutsugu Shiono1, Takashi Kubo, Atsushi Tanaka, Yasushi Ino, Tomoyuki Yamaguchi, Takashi Tanimoto, Takashi Yamano, Yoshiki Matsuo, Tsuyoshi Nishiguchi, Ikuko Teraguchi, Shingo Ota, Yuichi Ozaki, Makoto Orii, Kunihiro Shimamura, Hironori Kitabata, Kumiko Hirata, Toshio Imanishi, Takashi Akasaka.   

Abstract

BACKGROUND: A strategy of deferred percutaneous coronary intervention for coronary stenosis with fractional flow reserve (FFR) 0.75-0.80, termed the gray zone, remains a matter of debate. The aim of this study was to assess the safety of deferring revascularization for patients with FFR 0.75-0.80 compared with those with FFR >0.80. METHODS AND
RESULTS: We assessed 3-year clinical outcome in 150 patients with angiographically intermediate stenosis who had revascularization deferred on the basis of FFR ≥ 0.75 (FFR 0.75-0.80, n=56; FFR >0.80, n=94). Target vessel failure (TVF), defined as a composite of cardiac death, target vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR) was evaluated during follow-up. Cardiac death was observed in 1 patient with FFR 0.75-0.80. There was no target vessel-related MI in either group. The incidence of ischemia-driven TVR was higher in patients with FFR 0.75-0.80 than in those with FFR >0.80 (14% vs. 3%, P=0.020). TVF-free survival was significantly worse for the patients with FFR 0.75-0.80 than those with FFR >0.80 (hazard ratio, 5.2; 95% confidence intervals: 1.4-19.5; P=0.015).
CONCLUSIONS: Patients with FFR 0.75-0.80 were at higher risk of TVF mainly due to TVR than those with FFR >0.80.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410812     DOI: 10.1253/circj.CJ-14-0671

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

1.  Three-vessel fractional flow reserve measurement for predicting clinical prognosis in patients with coronary artery disease.

Authors:  Takashi Kubo; Hiroki Emori; Yosuke Katayama; Kosei Terada
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Comparison of mid-term clinical outcomes between on-label and off-label use of rotational atherectomy.

Authors:  Takayuki Mori; Kenichi Sakakura; Hiroshi Wada; Yousuke Taniguchi; Kei Yamamoto; Yusuke Adachi; Hiroshi Funayama; Shin-Ichi Momomura; Hideo Fujita
Journal:  Heart Vessels       Date:  2016-10-05       Impact factor: 2.037

Review 3.  Coronary Physiology Assessment for the Diagnosis and Treatment of Stable Ischemic Heart Disease.

Authors:  Ali E Denktas; David Paniagua; Hani Jneid
Journal:  Curr Atheroscler Rep       Date:  2016-10       Impact factor: 5.113

4.  Is Hyperaemia Essential for Accurate Functional Assessment of Coronary Stenosis Severity?

Authors:  Barry Hennigan; Keith Robertson; Colin Berry; Keith Oldroyd
Journal:  Interv Cardiol       Date:  2015-05

5.  Clinical Outcomes in Patients with Deferred Coronary Lesions according to Disease Severity Assessed by Fractional Flow Reserve.

Authors:  Ki Bum Won; Chang Wook Nam; Yun Kyeong Cho; Hyuck Jun Yoon; Hyoung Seob Park; Hyungseop Kim; Seongwook Han; Seung Ho Hur; Yoon Nyun Kim; Sang Hyun Park; Jung Kyu Han; Bon Kwon Koo; Hyo Soo Kim; Joon Hyung Doh; Sung Yun Lee; Hyoung Mo Yang; Hong Seok Lim; Myeong Ho Yoon; Seung Jea Tahk; Kwon Bae Kim
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

6.  Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial.

Authors:  Hironori Kitabata; Takashi Kubo; Yasutsugu Shiono; Kunihiro Shimamura; Yasushi Ino; Takashi Tanimoto; Yasushi Hayashi; Kenichi Komukai; Hiromichi Sougawa; Keizo Kimura; Masahiro Gohda; Toshikazu Hashizume; Masahiro Obana; Kazuisa Maeda; Junichi Yamaguchi; Takashi Akasaka
Journal:  Trials       Date:  2019-01-28       Impact factor: 2.279

7.  Regional Myocardial Work Measured by Echocardiography for the Detection of Myocardial Ischemic Segments: A Comparative Study With Invasive Fractional Flow Reserve.

Authors:  Ying Guo; Chenguang Yang; Xiang Wang; Zuowei Pei; Huolan Zhu; Xuyang Meng; Ziyu Zhou; Xiaotong Lang; Sun Ning; Ruisheng Zhang; Fang Wang
Journal:  Front Cardiovasc Med       Date:  2022-03-16

8.  Intravascular ultrasound characteristics in patients with intermediate coronary lesions and borderline fractional flow reserve measurements.

Authors:  Hyoung-Mo Yang; Hong-Seok Lim; Kyoung-Woo Seo; Byoung-Joo Choi; So-Yeon Choi; Myeong-Ho Yoon; Gyo-Seung Hwang; Seung-Jea Tahk
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  The utility of high-sensitivity C-reactive protein levels in patients with moderate coronary lesions and gray-zone fractional flow reserve.

Authors:  Lin Li; Qi Wei Liu; Zhe Li; Li Wang; Jian Hong Wang; Lei Song; Bin Li
Journal:  Anatol J Cardiol       Date:  2018-08-15       Impact factor: 1.596

10.  Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.

Authors:  Barry Hennigan; Colin Berry; Damien Collison; David Corcoran; Hany Eteiba; Richard Good; Margaret McEntegart; Stuart Watkins; John D McClure; Kenneth Mangion; Thomas Joseph Ford; Mark C Petrie; Stuart Hood; Paul Rocchiccioli; Aadil Shaukat; Mitchell Lindsay; Keith G Oldroyd
Journal:  Heart       Date:  2020-02-29       Impact factor: 5.994

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.